triamcinolone acetonide + verteporfin

Triamcinolone acetonide + verteporfin is a combination of two pharmaceutical agents with distinct mechanisms of action, primarily considered for ophthalmic use. Triamcinolone acetonide is a synthetic corticosteroid that exerts anti-inflammatory and immunosuppressive effects by activating glucocorticoid receptors, thereby reducing swelling, redness, and immune responses in tissues. It is used to treat various inflammatory conditions including skin disorders, joint inflammation, allergic rhinitis (as nasal spray), and macular edema associated with uveitis[4][5]. Verteporfin is a benzoporphyrin derivative photosensitizer used in photodynamic therapy; it accumulates in abnormal neovascular tissue within the eye and, upon activation by nonthermal red light (typically 693 nm) in the presence of oxygen, generates singlet oxygen and reactive oxygen species that locally damage vascular endothelium leading to vessel occlusion[8][10]. Verteporfin is approved for treating choroidal neovascularization due to age-related macular degeneration and other retinal diseases[6][8][10]. The combination may be explored or used off-label for synergistic management of ocular neovascular or inflammatory conditions.

Other names

triamcinolone acetonideverteporfin